SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
215 hedge funds and large institutions have $2.12B invested in Sage Therapeutics in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 74 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 224 → 215 (-9)
18% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 33
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
215
Holding in Top 10
2
Calls
$53.2M
Puts
$32.4M
Top Buyers
| 1 | +$40M | |
| 2 | +$18.2M | |
| 3 | +$16.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$15.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$9.46M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$11.9M | |
| 3 | -$11.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.8M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$10.2M |